Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/10/2011 | WO2011027308A1 Novel tumor markers |
03/10/2011 | WO2011027291A1 Sensor cartridge with dissolvable cover layer |
03/10/2011 | WO2011027221A1 Method of assessing islet function |
03/10/2011 | WO2011027146A2 Ultrasound & magnetic method |
03/10/2011 | WO2011027137A1 In-borehole gas monitor apparatus and method comprising a voc concentration analyser and a voc collector |
03/10/2011 | WO2011027132A1 Clec14a inhibitors |
03/10/2011 | WO2011027130A1 Methods, system and device to identify a type of test strip |
03/10/2011 | WO2011027099A1 Water-in-fuel sensor |
03/10/2011 | WO2011027092A1 Micro-fluidic structures |
03/10/2011 | WO2011027089A1 Quick extraction of cellular hepatotoxins |
03/10/2011 | WO2011026962A1 Biomarker for colorectal cancer |
03/10/2011 | WO2011026841A1 Method and device for identifying a material likely to generate eye or skin discomfort, tingling, or irritation |
03/10/2011 | WO2011026836A1 Carbon dioxide sensor |
03/10/2011 | WO2011026815A1 Compositions and methods for treating growth hormone deficiency |
03/10/2011 | WO2011026775A1 Carbon dioxide sensor |
03/10/2011 | WO2011026640A1 Es-ms of glycopeptides for analysis of glycosylation |
03/10/2011 | WO2011026450A1 Method for determining the quality of heparin |
03/10/2011 | WO2011026429A1 Methods and compositions for detection of lethal cell and uses thereof |
03/10/2011 | WO2011026249A1 Device and method for optically scanning a moving textile material |
03/10/2011 | WO2011026242A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
03/10/2011 | WO2011026216A1 Neuroprotective ganglioside compositions for use in treating or diagnosing huntington's disease |
03/10/2011 | WO2011026200A2 New methods for diagnosing autoimmune diseases |
03/10/2011 | WO2011026185A1 An assay for monitoring a neurological condition |
03/10/2011 | WO2011026177A1 A method of determining surface level, and a soil moisture sensor |
03/10/2011 | WO2011012848A8 Improvements relating to sensor devices |
03/10/2011 | WO2011007039A3 Method for extracting hydrolysed and native gluten |
03/10/2011 | WO2011007023A3 Device for clamping samples in mechanical tests on soft tissue |
03/10/2011 | WO2011004208A3 Sample imaging system and method for transmitting an image of cells or tissues located in a culturing space to data processing means |
03/10/2011 | WO2011000860A3 Human polypeptides that interact with hiv and htlv proteins |
03/10/2011 | WO2010151771A3 Optimized oligonucleotides and methods of using same for the detection, isolation, quantification, monitoring and sequencing of bordetella |
03/10/2011 | WO2010151031A3 Portable detector for metals and inflammable liquids, and method for detecting metals and inflammable liquids using same |
03/10/2011 | WO2010146588A3 Miniature disease optical spectroscopy diagnostic system |
03/10/2011 | WO2010145796A3 Biomarkers and methods for determining efficacy of anti-egfr antibodies in cancer therapy |
03/10/2011 | WO2010140774A3 Protein analysis method in which a data-independent analysis method and a data-dependent analysis method are combined |
03/10/2011 | WO2010139965A3 Device and method for determining the composition of a mixture of fluids |
03/10/2011 | WO2010126272A3 Method for detecting a ligand using fret biosensor |
03/10/2011 | WO2010124277A3 Materials and methods for assessing and mapping microbes and microbial biofilms on wounds |
03/10/2011 | WO2010121131A3 Quality control bioassays for nutriceutical and medicinal products |
03/10/2011 | WO2010120518A3 Sperm cell separation methods and compositions containing sperm cell targeting ligands for use therein |
03/10/2011 | WO2010115094A3 Methods for determine atherosclerosis regression, plaque stabilization and cardiovascular risk |
03/10/2011 | WO2010115025A3 Device and methods for isolating cells |
03/10/2011 | WO2010108164A3 Novel anti-parasitic compounds |
03/10/2011 | WO2010107734A3 Methods for detecting endometriosis |
03/10/2011 | WO2010091183A3 Non-invasive detection of complement-mediated inflammation using cr2-targeted nanoparticles |
03/10/2011 | WO2009102469A8 Regulation of cyclin d |
03/10/2011 | US20110061124 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants |
03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
03/10/2011 | US20110060605 Methods for predicting responsiveness of a disease or disorder to a receptor tyrosine kinase inhibitor by analysis of mutations in pik3ca |
03/10/2011 | US20110060554 Interference Detector and Methods |
03/10/2011 | US20110060532 Methods and compositions for the assessment of drug response |
03/10/2011 | US20110060530 Analyte Signal Processing Device and Methods |
03/10/2011 | US20110060529 Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker |
03/10/2011 | US20110060203 Analyzing Instrument |
03/10/2011 | US20110060128 Process for the purification of interleukin-4 and its muteins |
03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
03/10/2011 | US20110059953 Compounds for use in stabilizing p53 mutants |
03/10/2011 | US20110059924 Chemoprevention of Colorectal Cancer by Mesalamine/Sulfasalazine |
03/10/2011 | US20110059900 Diagnosing and treating hormone resistant cancers |
03/10/2011 | US20110059899 Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein |
03/10/2011 | US20110059898 Pro-oxidant anti-cancer compounds |
03/10/2011 | US20110059889 PEPTIDES THAT BLOCK THE BINDING OF IgG TO FcRn |
03/10/2011 | US20110059868 Process for amplifying nucleic acids |
03/10/2011 | US20110059861 Analysis of cell networks |
03/10/2011 | US20110059858 New biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof |
03/10/2011 | US20110059857 Markers of acute kidney failure |
03/10/2011 | US20110059854 Diagnostic and prognostic tests |
03/10/2011 | US20110059852 Compositions and methods for treating haematological proliferative disorders of meyloid origin |
03/10/2011 | US20110059851 SHOC2 Mutations Causing Noonan-Like Syndrome With Loose Anagen Hair |
03/10/2011 | US20110059556 Rapid and Continuous Analyte Processing in Droplet Microfluidic Devices |
03/10/2011 | US20110059555 Branched and multi-chain nucleic acid switches for sensing and screening |
03/10/2011 | US20110059554 Determining an expression status of human epidermal growth factor receptor 2 (her2) in a biological sample |
03/10/2011 | US20110059553 Methods and compositions for detecting herpes simplex virus type 2 |
03/10/2011 | US20110059552 Rubella e1 envelope protein variants and their use in detection of anti-rubella antibodies |
03/10/2011 | US20110059551 Assay Device |
03/10/2011 | US20110059550 MINIMALLY INVASIVE ASSESSMENT OF IgE MEDIATED ALLERGY |
03/10/2011 | US20110059549 Methods and systems for producing nanolipoprotein particles |
03/10/2011 | US20110059547 Uses of reagents in sample collection and cartridge systems |
03/10/2011 | US20110059543 Methods for detecting or monitoring cancer using lpe as a marker |
03/10/2011 | US20110059542 Detection of nucleic acids by target-specific hybrid capture method |
03/10/2011 | US20110059541 Method for Obtaining Information on Formation of Double-Stranded Nucleic Acid |
03/10/2011 | US20110059540 Identifying susceptibility of a subject to cardiac therapy based on determination of a cardiac troponin, scd40l, and c-reactive protein |
03/10/2011 | US20110059539 L-fabp, natriuretic peptides, and cardiac troponins in subjects in need of cardiac therapy |
03/10/2011 | US20110059538 Diffraction gratings comprising porous materials and diffraction-based sensors comprising porous materials |
03/10/2011 | US20110059537 Method for estimating risk of acute kidney injury |
03/10/2011 | US20110059536 Hexavalent chromium detector |
03/10/2011 | US20110059535 Electronic Methods for the Detection of Analytes |
03/10/2011 | US20110059534 Determination of testosterone by mass spectrometry |
03/10/2011 | US20110059533 Fluorescence detection system, method, and device for measuring biomolecules |
03/10/2011 | US20110059532 Monitoring of frying oil quality using combined optical interrogation methods and devices |
03/10/2011 | US20110059524 Human cdr-grafted antibody and antibody fragment thereof |
03/10/2011 | US20110059522 Nucleic acids encoding a house dust mite allergen, der p iii, and uses thereof |
03/10/2011 | US20110059521 Device and method for monitoring inhibition of platelet function |
03/10/2011 | US20110059473 Proteins with pteridine glycosyltransferase activity and analysis method using the same |
03/10/2011 | US20110059472 Reagents and methods for detecting influenza virus proteins |
03/10/2011 | US20110059471 Antibody having an immune-enhancement function |
03/10/2011 | US20110059470 Tumor Microenvironment of metastasis (TMEM) and uses thereof in diagnosis, prognosis and treatment of tumors |
03/10/2011 | US20110059469 Anti-cldn6 antibody |
03/10/2011 | US20110059468 Magnetic separation device for cell sorting and analysis |
03/10/2011 | US20110059467 Controlled modification of semiconductor nanocrystals |
03/10/2011 | US20110059466 Support for electrophoresis including hydrophobic polymer membrane, and electrophoretic separation method using the same |